lobbying_activities: 2681495

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2681495	3700fff0-d18a-4c7c-9d95-cbf12831bbbf	Q3	KOUNTOUPES DENHAM CARR & REID, LLC	320918	GLENMARK PHARMACEUTICALS, INC., USA	2021	third_quarter	PHA	Issues related to affordability, essential medicine manufacturing and supply chain, and pricing of pharmaceuticals. General issues related to the generic drug industry. Issues related to H.R. 2853, the BLOCKING Act of 2021.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2021-10-15T12:10:43.697000-04:00